Novel SCD1 Modulator Reduced Liver Fat in NASH Patients

(MedPage Today) -- Dose-response pattern seen for aramchol in phase IIb ARREST trial
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news